Yang Hong Yu, Fu Yan, Li Yi, Jang Moon-Sun, Lee Jung Hee, Lee Doo Sung
College of Materials Science and Engineering, Jilin Institute of Chemical Technology, Jilin City, 132022, P. R. China.
J Mater Chem B. 2018 Sep 21;6(35):5562-5569. doi: 10.1039/c8tb01798k. Epub 2018 Aug 22.
Multifunctional nanoplatforms that can combine diagnostic functions and therapeutic capabilities are highly required for the construction of novel cancer diagnosis-therapy integrative systems. In this work, we developed multifunctional and tumor redox-responsive magnetic nanoclusters (RMNs) by the self-assembly of iron oxide nanoparticles with a chlorin e6 (Ce6)-disulfide-linked polymer ligand. The core of RMNs could enhance the T-weighted MR contrast capability, and the surface ligand could improve the system stability and load Ce6. In addition, the obtained RMNs also exhibited excellent biocompatibility and higher cytotoxicity upon near infrared (NIR)-irradiation. These RMNs with a size of ∼90 nm can effectively facilitate their accumulation in tumor sites through the enhanced permeability and retention (EPR) effect and subsequently are endocytosed into a highly reductive intracellular environment that activates fluorescence and photodynamic therapeutic antitumor activity. Furthermore, the in vivo imaging and therapy results not only confirmed that RMNs can as bimodal imaging probes for the early-stage diagnosis of cancer but also demonstrated the superior photodynamic therapeutic efficiency of RMNs in suppressing tumor growth. These results indicated that RMNs show great potential for simultaneous diagnostic imaging and photodynamic therapy.
构建新型癌症诊断-治疗一体化系统迫切需要能够结合诊断功能和治疗能力的多功能纳米平台。在这项工作中,我们通过氧化铁纳米颗粒与二硫化物连接的氯e6(Ce6)聚合物配体自组装,开发了多功能且对肿瘤氧化还原有响应的磁性纳米簇(RMNs)。RMNs的核心可以增强T加权磁共振成像对比能力,表面配体可以提高系统稳定性并负载Ce6。此外,所获得的RMNs在近红外(NIR)照射下还表现出优异的生物相容性和更高的细胞毒性。这些尺寸约为90nm的RMNs可以通过增强的渗透和滞留(EPR)效应有效地促进它们在肿瘤部位的积累,随后被内吞到高度还原的细胞内环境中,从而激活荧光和光动力治疗抗肿瘤活性。此外,体内成像和治疗结果不仅证实了RMNs可以作为癌症早期诊断的双模态成像探针,还证明了RMNs在抑制肿瘤生长方面具有卓越的光动力治疗效率。这些结果表明,RMNs在同时进行诊断成像和光动力治疗方面具有巨大潜力。
ACS Appl Mater Interfaces. 2017-5-25
J Control Release. 2020-11-10
ACS Appl Mater Interfaces. 2016-1-5
Adv Healthc Mater. 2020-5